Charles Steadman
Princess Alexandra Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles Steadman.
Gut | 1998
Andrew Pascoe; Paul Kerlin; Charles Steadman; Andrew D. Clouston; Dianne Jones; Lawrie W. Powell; E. C. Jazwinska; S. V. Lynch; R. W. Strong
BACKGROUND Following orthotopic liver transplantation (OLT) histological examination of explant livers from patients with alcoholic liver disease (ALD) sometimes shows extensive iron deposits in a distribution suggestive of homozygous haemochromatosis. AIMS To use haemochromatosis gene (HFE) assays to distinguish between ALD with notable siderosis and hereditary haemochromatosis. To evaluate the possible influence of spur cell haemolytic anaemia on hepatic iron loading. PATIENTS Thirty seven patients with ALD were abstinent for at least six months prior to OLT. Twenty three patients had transferrin saturations greater than 55%, 16 also had increased serum ferritin (>350 micrograms/l). Eight of 37 (22%) explant livers had grade 3 or 4 hepatic iron deposition, predominantly in hepatocytes. Of these, four had a hepatic iron index greater than 1. 9 and most seemed to have spur cell haemolytic anaemia. METHODS Mutation analysis for C282Y and H63D mutations was performed on DNA extracts from peripheral blood or explant liver. Spur cell haemolytic anaemia was diagnosed when the haemoglobin was 105 g/l in the presence of notable acanthocytosis. RESULTS None of the eight patients with grade 3 or 4 hepatic iron had evidence of the C282Y mutation. Two of the eight were heterozygous for H63D. None of the remaining 28 patients tested showed homozygous HFE mutations. Spur cell anaemia was present in six of the eight patients with heavy iron deposition and only one of the remaining patients. CONCLUSIONS The HFE mutation was not present in these patients with advanced ALD and heavy iron loading. Spur cell haemolytic anaemia provides an alternative potential mechanism for the heavy iron loading.
Transplantation | 2000
Yuichi Nakazawa; Neal I. Walker; Paul Kerlin; Charles Steadman; S. V. Lynch; R. W. Strong; Andrew D. Clouston
BACKGROUND Centrilobular necrosis (CLN) in liver allografts can be a difficult lesion to interpret histologically. Although long recognized in association with developing chronic rejection, recent studies have described the lesion in association with a number of other disease processes. To clarify the histologic features that could allow a specific diagnosis to be made and to determine the outcome in different diagnostic groups, we assessed biopsies from 54 patients with CLN. METHODS Biopsies were classified as CLN with acute cellular rejection (ACR), CLN with hepatitis, CLN with developing chronic rejection (CR), and CLN of other etiology. Histologic features were assessed and then compared between groups, and clinical outcomes were noted. RESULTS Discriminating features for the different groups were as follows: CLN and ACR showed bile duct injury, endothelialitis, and acinar congestion. CLN and CR showed severe bile duct injury, bile duct loss, or centrilobular swelling. CLN and hepatitis was often a diagnosis of exclusion, although interface hepatitis was more common in this group. Cases of autoimmune hepatitis usually demonstrated plasma cell predominance in the portal and acinar inflammatory infiltrate. Significantly, there was considerable overlap in the histologic features between the groups, accounting for the diagnostic difficulty. Patients in whom the CLN was associated with CR or vascular complications generally required retransplantation or died, but in the groups with ACR and hepatitis, the outcome was more favorable. CONCLUSIONS With regard to most liver allograft biopsies showing late CLN, it is possible to make a specific diagnosis despite overlapping histologic features; this allows specific therapy to be instituted. Ultimately this is likely to contribute to improved graft survival.
Journal of Gastroenterology and Hepatology | 1987
Charles Steadman; Clinton Teague; Paul Kerlin; Owen Harris; Kevin J Hourigan; John Sampson
Collagenous colitis is characterized by the presence of a thick subepithelial collagen band in the colonic mucosa. The condition was diagnosed on rectal biopsy in 10 patients (one male, nine females) who presented with watery diarrhoea. Although rectal mucosal erythema was present in three and ulceration in two, the mucosa was of normal endoscopic appearance in five of the patients. There was marked variability in the thickness of the submucosal collagen band, both between and within individuals. Empirical drug therapy included sulphasalazine, glucocorticoids and antidiarrhoeals. All patients reported symptomatic improvement.
Gastroenterology | 1988
Charles Steadman; Paul Kerlin; Clinton Teague; Peter Stephenson
Hepatology | 2000
Yuichi Nakazawa; Julie R. Jonsson; Neal I. Walker; Paul Kerlin; Charles Steadman; S. V. Lynch; R. W. Strong; Andrew D. Clouston
Journal of Hepato-biliary-pancreatic Surgery | 1999
Toru Kubota; Andrew Thomson; Andrew D. Clouston; Yuichi Nakazawa; Charles Steadman; Paul Kerlin; Hiroshi Shimada; Glenda A. Balderson; S. V. Lynch; R. W. Strong
Australian and New Zealand Journal of Medicine | 1988
Charles Steadman; C. Teague; J. Harper; P. Hayes; N. Nathan; Owen Harris; Paul Kerlin
Liver Transplantation | 1996
Michael J. Burt; Elizabeth C. Jazwinska; S. V. Lynch; Paul Kerlin; Devinder Gill; Charles Steadman; Julie R. Jonsson; R. W. Strong; Elizabeth E. Powell
Hepato-gastroenterology | 2001
Winsome J. Abbott; Andrew Thomson; Charles Steadman; Michelle L. Gatton; Clifton M. Bothwell; Paul Kerlin; D. Wall; S. V. Lynch
Archive | 2000
Ac Omparative; Yuichi Nakazawa; Neal I. Walker; Paul Kerlin; Charles Steadman; S. V. Lynch; R. W. Strong; Andrew D. Clouston